NA
SRNE

Navellier & Associates’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Navellier & Associates’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-42,767
Closed -$354K – 349
2021
Q1 		$354K Buy
42,767
+4,314
+11% +$35.7K 0.06% 219
2020
Q4 		$262K Buy
+38,453
New +$262K 0.05% 238